References
- Meadows , GG and Oeser , DE . 1983 . “Response of B16 melanoma‐bearing mice to varying dietary levels of phenylalanine and tyrosine” . Nutr Rep Int , 28 : 1073 – 1082 .
- Pierson , HF and Meadows , GG . 1983 . “Sodium ascorbate enhancement of carbidopa‐levodopa methyl ester antitumor activity against pigmented B16 melanoma” . Cancer Res , 43 : 2047 – 2051 .
- Meadows , GG , Pierson , HF , Abdallah , RM and Desai , PR . 1982 . “Dietary influence of tyrosine and phenylalanine on the response of B16 melanoma to carbidopa‐levodopa methyl ester chemotherapy” . Cancer Res , 42 : 3056 – 3063 .
- Abdallah , RM , Starkey , JR and Meadows , GG . 1987 . “Dietary restriction of tyrosine and phenylalanine: inhibition of metastasis of three rodent tumors” . JNCI , 78 : 759 – 766 .
- Elstad , CA , Meadows , GG and Abdallah , RM . 1990 . “Specificity of the suppression of metastatic phenotype by tyrosine and phenylalanine restriction” . Clin Exp Metastasis , 8 : 393 – 416 .
- Elstad , CA and Meadows , GG . 1993 . “Modulation of B16‐BL6 murine melanoma metastatic phenotype by tyrosine and phenylalanine restriction in the absence of host selection pressures” . Anticancer Res , 13 : 523 – 528 .
- Ershler , WB , Berman , E and Moore , AL . 1986 . “Slower B16 melanoma growth but greater pulmonary colonization in calorie‐restricted mice” . JNCI , 76 : 81 – 85 .
- Elstad , CA and Meadows , GG . 1990 . “Phenotypic stability of B16‐BL6 melanoma exposed to low levels of tyrosine and phenylalanine” . Anticancer Res , 10 : 1313 – 1318 .
- Green , A , Bain , C , McLennan , R and Siskind , V . 1986 . “Risk factors for cutaneous melanoma in Queensland” . In Recent Results in Cancer Research. Epidemiology of Malignant Melanoma , Edited by: Gallagher , RP . vol 102 , 76 – 97 . Berlin : Springer‐Verlag .
- Poste , G , Doll , J , Hart , IR and Fidler , IJ . 1980 . "In vitro selection of murine B16 melanoma variants with enhanced tissue‐invasive properties” . Cancer Res , 40 : 1636 – 1644 .
- Yu , Z‐X , Biro , S , Fu , Y‐M , Sanchez , J Smale , G . 1993 . “Localization of basic fibroblast growth factor in bovine endothelial cells: immuno‐histochemical and biochemical studies” . Exp Cell Res , 204 : 247 – 259 .
- Hart , IR . 1979 . “The selection and characterization of an invasive variant of the B16 melanoma” . Am J Pathol , 97 : 587 – 600 .
- Ewen , ME , Sluss , HK , Whitehouse , LL and Livingston , DM . 1993 . “TGF0 inhibition of Cdk4 synthesis is linked to cell cycle arrest” . Cell , 74 : 1009 – 1020 .
- Schutte , B , Reynders , MMJ , Bosman , FT and Blijham , GH . 1985 . “Flow cytometric determination of DNA ploidy level in nuclei isolated from paraffin‐embedded tissue” . Cytometry , 6 : 26 – 30 .
- Von Roenn , JH , Kheir , SM , Wolter , JM and Coon , JS . 1986 . “Significance of DNA abnormalities in primary malignant melanoma and nevi, a retrospective flow cytometric study” . Cancer Res , 46 : 3192 – 3195 .
- Biro , S , Fu , Y‐M , Yu , Z‐X and Epstein , SE . 1993 . “Inhibitory effects of antisense oligodeoxynucleotides targeting c‐myc mRNA on smooth muscle proliferation and migration” . Proc Natl Acad Sci USA , 90 : 654 – 658 .
- Speir , E and Epstein , SE . 1992 . “Inhibition of smooth muscle cell proliferation by an antisense oligodeoxynucleotide targeting the messenger RNA encoding proliferating cell nuclear antigen” . Circulation , 86 : 538 – 547 .
- Zhang , W , Grasso , L , McClain , CD , Gambel , AM Cha , Y . 1995 . “p53‐Independent induction of WAFA1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation” . Cancer Res , 55 : 668 – 674 .
- Waseem , NH and Lane , DP . 1990 . “Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA)” . J Cell Sci , 96 : 121 – 129 .
- Bravo , R , Frank , R , Blundell , PA and MacDonald‐Bravo , H . 1987 . “Cy‐clin/PCNA is the auxiliary protein of DNA polymerase 8” . Nature , 326 : 515 – 517 .
- Sherr , CJ . 1994 . “Gl phase progression: cycling on cue” . Cell , 79 : 551 – 555 .
- Toyoshima , H and Hunter , T . 1994 . “p27, a novel inhibitor of Gl cyclin‐CDK protein kinase activity, is related to p21” . Cell , 78 : 67 – 74 .
- Hirama , T and Koeffler , HP . 1995 . “Role of the cyclin‐dependent kinase inhibitors in the development of cancer” . Blood , 86 : 841 – 854 .
- Iida , A , Hirose , K , Arai , M , Yamaguchi , A and Naksgawara , G . 1995 . “Relationships among the expression of epidermal growth factor receptor, proliferating cell nuclear antigen labeling index, and lymph node metastasis in gastric cancer” . Oncology , 52 : 189 – 195 .
- Tanaka , S , Haruma , K , Tatsuta , S , Hiraga , Y Teixeira , CR . 1995 . “Proliferating cell nuclear antigen expression correlates with the met‐astatic potential of submucosal invasive colorectal carcinoma” . Oncology , 52 : 134 – 139 .
- Hunter , T and Pines , J . 1994 . “Cyclins and cancer. II. Cyclin D and CDK inhibitors come of age” . Cell , 79 : 573 – 582 .
- Sherr , CJ . 1993 . “Premature p34afc2 activation required for apoptosis” . Science , 73 : 1059 – 1065 .
- Matthias , P and Herskowitz , I . 1994 . “Joining the complex: cyclin‐dependent kinase inhibitory proteins and the cell cycle” . Cell , 79 : 181 – 184 .
- Ponce‐Castaneda , MV , Lee , MH , Latres , E , Polyak , K Lacombe , L . 1995 . “p27Kipl: chromosomal mapping to 12p12–13.1 and absence of mutations in human tumors” . Cancer Res , 55 : 1211 – 1214 .
- Singh , RK and Siegal , GP . 1995 . “Amino acid transport systems modulate human tumor cell growth and invasion: a working hypothesis” . Med Hypotheses , 44 : 195 – 201 .
- Mcmillan , TJ , Rao , J and Hart , IR . 1986 . “Enhancement of experimental metastasis by pretreatment of tumour cells with hydroxyurea” . Int J Cancer , 38 : 61 – 65 .
- Iwaski , T , Shinkai , K , Mukai , M , Yoshioka , K Fujii , Y . 1995 . “Cell‐cycle‐dependent invasion in vitro by rat ascites hepatoma cells” . Int J Cancer , 63 : 282 – 287 .
- Bates , S , Bonnetta , L , MacAllan , D , Parry , D Holder , A . 1994 . “CDK6 (PLSTIRE) and CDK (PSK‐J3) are a distinct subset of the cyclin‐dependent kinases that associate with cyclin D1” . Oncogene , 9 : 71 – 79 .
- Weinstat‐Saslow , D , Merino , MJ , Manrow , RE , Lawrence , JA Bluth , RF . 1994 . “Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non‐malignant lesions” . Nature Med , 1 : 1257 – 1260 .